Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Przeglądasz jako GOŚĆ

Wyszukujesz frazę ""The Journal of antimicrobial chemotherapy [J Antimicrob Chemother] NLMUID: 7513617"" wg kryterium: JN


Tytuł :
In vitro activity of rezafungin against common and rare Candida species and Saccharomyces cerevisiae.
Autorzy :
Tóth Z; Department of Medical Microbiology, Faculty of Medicine, University of Debrecen, Debrecen, Hungary.; Doctoral School of Pharmaceutical Sciences, University of Debrecen, Debrecen, Hungary.
Forgács L; Department of Medical Microbiology, Faculty of Medicine, University of Debrecen, Debrecen, Hungary.; Doctoral School of Pharmaceutical Sciences, University of Debrecen, Debrecen, Hungary.
Locke JB; Cidara Therapeutics, Inc., 6310 Nancy Ridge Dr., Suite 101, San Diego, CA, 92121, USA.
Kardos G; Department of Medical Microbiology, Faculty of Medicine, University of Debrecen, Debrecen, Hungary.
Nagy F; Department of Medical Microbiology, Faculty of Medicine, University of Debrecen, Debrecen, Hungary.; Doctoral School of Pharmaceutical Sciences, University of Debrecen, Debrecen, Hungary.
Kovács R; Department of Medical Microbiology, Faculty of Medicine, University of Debrecen, Debrecen, Hungary.; Faculty of Pharmacy, University of Debrecen, Debrecen, Hungary.
Szekely A; UK National Mycology Reference Laboratory (MRL), Public Health England South-West, Bristol, UK.
Borman AM; UK National Mycology Reference Laboratory (MRL), Public Health England South-West, Bristol, UK.
Majoros L; Department of Medical Microbiology, Faculty of Medicine, University of Debrecen, Debrecen, Hungary.
Pokaż więcej
Źródło :
The Journal of antimicrobial chemotherapy [J Antimicrob Chemother] 2019 Dec 01; Vol. 74 (12), pp. 3505-3510.
Typ publikacji :
Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Antifungal Agents/*pharmacology
Candida/*drug effects
Echinocandins/*pharmacology
Saccharomyces cerevisiae/*drug effects
Candida/classification ; Candida glabrata/drug effects ; Candida parapsilosis/drug effects ; Candida tropicalis/drug effects ; Microbial Sensitivity Tests
Czasopismo naukowe
Tytuł :
Plasma exposures following posaconazole delayed-release tablets in immunocompromised children and adolescents.
Autorzy :
Tragiannidis A; Infectious Disease Research Program, Center for Bone Marrow Transplantation and Dept. of Pediatric Hematology and Oncology, University Children's Hospital Münster, Münster, Germany.; Hematology Oncology Unit, 2nd Department of Pediatrics, Aristotle University of Thessaloniki, AHEPA Hospital, Thessaloniki, Greece.
Herbrüggen H; Infectious Disease Research Program, Center for Bone Marrow Transplantation and Dept. of Pediatric Hematology and Oncology, University Children's Hospital Münster, Münster, Germany.
Ahlmann M; Infectious Disease Research Program, Center for Bone Marrow Transplantation and Dept. of Pediatric Hematology and Oncology, University Children's Hospital Münster, Münster, Germany.
Vasileiou E; Hematology Oncology Unit, 2nd Department of Pediatrics, Aristotle University of Thessaloniki, AHEPA Hospital, Thessaloniki, Greece.
Gastine S; Department of Pharmaceutical and Medical Chemistry, University of Münster, Münster, Germany.
Thorer H; Infectious Disease Research Program, Center for Bone Marrow Transplantation and Dept. of Pediatric Hematology and Oncology, University Children's Hospital Münster, Münster, Germany.
Fröhlich B; Infectious Disease Research Program, Center for Bone Marrow Transplantation and Dept. of Pediatric Hematology and Oncology, University Children's Hospital Münster, Münster, Germany.
Müller C; Department of Pharmacology, University of Cologne, Cologne, Germany.
Groll AH; Infectious Disease Research Program, Center for Bone Marrow Transplantation and Dept. of Pediatric Hematology and Oncology, University Children's Hospital Münster, Münster, Germany.
Pokaż więcej
Źródło :
The Journal of antimicrobial chemotherapy [J Antimicrob Chemother] 2019 Dec 01; Vol. 74 (12), pp. 3573-3578.
Typ publikacji :
Journal Article; Observational Study
MeSH Terms :
Immunocompromised Host*
Antifungal Agents/*administration & dosage
Antifungal Agents/*blood
Triazoles/*administration & dosage
Triazoles/*blood
Administration, Oral ; Adolescent ; Antifungal Agents/pharmacokinetics ; Chemoprevention ; Child ; Child, Preschool ; Delayed-Action Preparations ; Female ; Humans ; Liver/drug effects ; Liver Function Tests ; Male ; Mycoses/prevention & control ; Plasma ; Retrospective Studies ; Tablets ; Triazoles/pharmacokinetics
Czasopismo naukowe
Tytuł :
Matched-paired analysis of patients treated for invasive mucormycosis: standard treatment versus posaconazole new formulations (MoveOn).
Autorzy :
Salmanton-García J; University of Cologne, Faculty of Medicine and University Hospital of Cologne, Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf (CIO ABCD), European Diamond Excellence Center for Medical Mycology (ECMM), Cologne, Germany.
Seidel D; University of Cologne, Faculty of Medicine and University Hospital of Cologne, Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf (CIO ABCD), European Diamond Excellence Center for Medical Mycology (ECMM), Cologne, Germany.; Cologne Excellence Cluster on Cellular Stress Responses in Aging-Associated Diseases (CECAD), University of Cologne, Cologne, Germany.
Koehler P; University of Cologne, Faculty of Medicine and University Hospital of Cologne, Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf (CIO ABCD), European Diamond Excellence Center for Medical Mycology (ECMM), Cologne, Germany.; Cologne Excellence Cluster on Cellular Stress Responses in Aging-Associated Diseases (CECAD), University of Cologne, Cologne, Germany.
Mellinghoff SC; University of Cologne, Faculty of Medicine and University Hospital of Cologne, Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf (CIO ABCD), European Diamond Excellence Center for Medical Mycology (ECMM), Cologne, Germany.
Herbrecht R; Department of Oncology and Hematology, Hôpitaux Universitaires de Strasbourg and Université de Strasbourg, Inserm, UMR-S1113/IRFAC, Strasbourg, France.
Klimko N; Department of Clinical Mycology, Allergy and Immunology, North Western State Medical University, Saint Petersburg, Russia.
Ráčil Z; Department of Internal Medicine-Hematology and Oncology, Masaryk University, Brno, Czech Republic.; University Hospital Brno, Brno, Czech Republic.
Falces-Romero I; Clinical Microbiology and Parasitology Department, University Hospital La Paz, Madrid, Spain.
Ingram P; Department of Infectious Diseases, Royal Perth Hospital, Perth, WA, Australia.; School of Pathology and Laboratory Medicine, University of Western Australia, Perth, WA, Australia.
Benítez-Peñuela MÁ; Center of Microbiological Research of Cesar (CIMCE), Rosario Pumarejo de López Hospital, Laura Daniela Clinic, Médicos Clinic LTDA, Valledupar, Colombia.
Rodríguez JY; Center of Microbiological Research of Cesar (CIMCE), Rosario Pumarejo de López Hospital, Laura Daniela Clinic, Médicos Clinic LTDA, Valledupar, Colombia.
Desoubeaux G; Parasitology, Mycology and Tropical Medicine Service, University Hospital of Tours, Tours, France.; Inserm U1100, Tours University, Tours, France.
Barać A; Clinic for Infectious and Tropical Diseases, Clinical Centre of Serbia, Faculty of Medicine, University of Belgrade, Serbia.
García-Vidal C; Service of Infectious Diseases, Clínic Hospital, University of Barcelona, Institute of Biomedical Research August Pi i Sunyer, Barcelona, Spain.
Hoenigl M; Division of Infectious Diseases, University of California San Diego, San Diego, CA, USA.; Section of Infectious Diseases and Tropical Medicine, Department of Internal Medicine, Medical University of Graz, Graz, Austria.
Mehta SR; Division of Infectious Diseases, University of California San Diego, San Diego, CA, USA.; Department of Medicine, San Diego Veterans Affairs Medical Center San Diego, CA, USA.
Cheng MP; Division of Infectious Diseases, Departments of Medicine, Microbiology and Immunology, Research Institute of the McGill University Health Centre, Montreal, QC, Canada.
Klyasova G; Department of Clinical Microbiology, Mycology and Antibiotic Therapy, National Research Center for Hematology, Moscow, Russia.
Heinz WJ; Department of Internal Medicine II, Julius Maximilians University, Würzburg, Germany.
Iqbal N; Section of Pulmonology and Critical Care, Department of Medicine, Aga Khan University Hospital, Karachi, Pakistan.
Krause R; Section of Infectious Diseases and Tropical Medicine, Department of Internal Medicine, Medical University of Graz, Graz, Austria.
Ostermann H; Department of Internal Medicine III, University of Munich, Munich, Germany.
Penack O; Department for Hematology, Oncology and Tumorimmunology, Charité University Medicine Berlin, Campus Virchow Clinic, Berlin, Germany.
Schalk E; Department of Haematology and Oncology, Medical Centre, Otto-von-Guericke University Magdeburg, Magdeburg, Germany.
Sheppard DC; Division of Infectious Diseases, Departments of Medicine, Microbiology and Immunology, Research Institute of the McGill University Health Centre, Montreal, QC, Canada.
Willinger B; Division of Clinical Microbiology, Department of Laboratory Medicine, Medical University of Vienna, Vienna, Austria.
Wisplinghoff H; University of Cologne, Institute for Medical Microbiology, Immunology and Hygiene, Cologne, Germany.; Wisplinghoff Laboratories, Cologne, Germany.; Institute for Virology and Clinical Microbiology, Witten/Herdecke University, Witten, Germany.
Vehreschild JJ; University of Cologne, Faculty of Medicine and University Hospital of Cologne, Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf (CIO ABCD), European Diamond Excellence Center for Medical Mycology (ECMM), Cologne, Germany.; German Centre for Infection Research (DZIF), partner site Bonn - Cologne, Cologne, Germany.; Center for Integrated Oncology CIO Köln/Bonn, Medical Faculty, University of Cologne, Cologne, Germany.
Cornely OA; University of Cologne, Faculty of Medicine and University Hospital of Cologne, Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf (CIO ABCD), European Diamond Excellence Center for Medical Mycology (ECMM), Cologne, Germany.; Cologne Excellence Cluster on Cellular Stress Responses in Aging-Associated Diseases (CECAD), University of Cologne, Cologne, Germany.; German Centre for Infection Research (DZIF), partner site Bonn - Cologne, Cologne, Germany.; Center for Integrated Oncology CIO Köln/Bonn, Medical Faculty, University of Cologne, Cologne, Germany.; Clinical Trials Centre Cologne (ZKS Köln), University of Cologne, Cologne, Germany.; Center for Molecular Medicine Cologne (CMMC), University of Cologne, Cologne, Germany.
Vehreschild MJGT; University of Cologne, Faculty of Medicine and University Hospital of Cologne, Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf (CIO ABCD), European Diamond Excellence Center for Medical Mycology (ECMM), Cologne, Germany.; German Centre for Infection Research (DZIF), partner site Bonn - Cologne, Cologne, Germany.; Center for Integrated Oncology CIO Köln/Bonn, Medical Faculty, University of Cologne, Cologne, Germany.; Department of Internal Medicine, Infectious Diseases, Goethe University, Frankfurt, Frankfurt am Main, Germany.
Pokaż więcej
Corporate Authors :
FungiScope® ECMM/ISHAM Working Group
Źródło :
The Journal of antimicrobial chemotherapy [J Antimicrob Chemother] 2019 Nov 01; Vol. 74 (11), pp. 3315-3327.
Typ publikacji :
Clinical Trial; Journal Article; Observational Study; Research Support, Non-U.S. Gov't
MeSH Terms :
Antifungal Agents/*administration & dosage
Invasive Fungal Infections/*drug therapy
Mucormycosis/*drug therapy
Triazoles/*administration & dosage
Adolescent ; Adult ; Aged ; Amphotericin B/therapeutic use ; Antifungal Agents/chemistry ; Child ; Child, Preschool ; Drug Compounding ; Female ; Humans ; Infant ; Infant, Newborn ; Male ; Matched-Pair Analysis ; Middle Aged ; Mucorales/drug effects ; Mucormycosis/blood ; Prospective Studies ; Registries ; Triazoles/chemistry ; Young Adult
Czasopismo naukowe
Tytuł :
MSG-10: a Phase 2 study of oral ibrexafungerp (SCY-078) following initial echinocandin therapy in non-neutropenic patients with invasive candidiasis.
Autorzy :
Spec A; Washington University School of Medicine, St Louis, MO, USA.
Pullman J; Mercury Street Medical, Butte, MT, USA.
Thompson GR; University of California-Davis, Sacramento, CA, USA.
Powderly WG; Washington University School of Medicine, St Louis, MO, USA.
Tobin EH; Albany Medical Center, Albany, NY, USA.
Vazquez J; Medical College of Georgia/Augusta University, Augusta, GA, USA.
Wring SA; Scynexis, Inc., Jersey City, NJ, USA.
Angulo D; Scynexis, Inc., Jersey City, NJ, USA.
Helou S; Scynexis, Inc., Jersey City, NJ, USA.
Pappas PG; University of Alabama, Birmingham, AL, USA.
Pokaż więcej
Corporate Authors :
Mycoses Study Group
Źródło :
The Journal of antimicrobial chemotherapy [J Antimicrob Chemother] 2019 Oct 01; Vol. 74 (10), pp. 3056-3062.
Typ publikacji :
Clinical Trial, Phase II; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
MeSH Terms :
Antifungal Agents/*pharmacokinetics
Antifungal Agents/*therapeutic use
Candidiasis, Invasive/*drug therapy
Echinocandins/*therapeutic use
Glycosides/*pharmacokinetics
Glycosides/*therapeutic use
Triterpenes/*pharmacokinetics
Triterpenes/*therapeutic use
Administration, Oral ; Adult ; Aged ; Candida/drug effects ; Echinocandins/pharmacokinetics ; Female ; Fluconazole/pharmacokinetics ; Fluconazole/therapeutic use ; Humans ; Male ; Micafungin/pharmacokinetics ; Micafungin/therapeutic use ; Microbial Sensitivity Tests/methods ; Middle Aged
Czasopismo naukowe
Tytuł :
In vitro antifungal activity of a novel topical triazole PC945 against emerging yeast Candida auris.
Autorzy :
Rudramurthy SM; Medical Microbiology, Postgraduate Institute of Medical Education & Research, Chandigarh, India.
Colley T; Pulmocide Ltd, London, UK.
Abdolrasouli A; Department of Medical Microbiology, North West London Pathology, Imperial College Healthcare NHS Trust, London, UK.; National Heart and Lung Institute, Imperial College School of Medicine, London, UK.
Ashman J; Pulmocide Ltd, London, UK.
Dhaliwal M; Medical Microbiology, Postgraduate Institute of Medical Education & Research, Chandigarh, India.
Kaur H; Medical Microbiology, Postgraduate Institute of Medical Education & Research, Chandigarh, India.
Armstrong-James D; National Heart and Lung Institute, Imperial College School of Medicine, London, UK.; Department of Microbiology, Royal Brompton Hospital, Royal Brompton and Harefield NHS Trust, London, UK.
Strong P; Pulmocide Ltd, London, UK.
Rapeport G; Pulmocide Ltd, London, UK.
Schelenz S; Department of Microbiology, Royal Brompton Hospital, Royal Brompton and Harefield NHS Trust, London, UK.
Ito K; Pulmocide Ltd, London, UK.
Chakrabarti A; Medical Microbiology, Postgraduate Institute of Medical Education & Research, Chandigarh, India.
Pokaż więcej
Źródło :
The Journal of antimicrobial chemotherapy [J Antimicrob Chemother] 2019 Oct 01; Vol. 74 (10), pp. 2943-2949.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Antifungal Agents/*pharmacology
Benzamides/*pharmacology
Candida/*drug effects
Triazoles/*pharmacology
Asia ; Candida parapsilosis/drug effects ; Candidiasis/microbiology ; Humans ; Microbial Sensitivity Tests ; Tertiary Care Centers ; United Kingdom ; United States
Czasopismo naukowe
Tytuł :
Clinical experience with new formulation SUBA®-itraconazole for prophylaxis in patients undergoing stem cell transplantation or treatment for haematological malignancies.
Autorzy :
Nield B; Department of Microbiology and Infectious Disease, Royal Prince Alfred Hospital, Sydney, Australia.
Larsen SR; Institute of Haematology, Royal Prince Alfred Hospital, Sydney, Australia.
van Hal SJ; Department of Microbiology and Infectious Disease, Royal Prince Alfred Hospital, Sydney, Australia.
Pokaż więcej
Źródło :
The Journal of antimicrobial chemotherapy [J Antimicrob Chemother] 2019 Oct 01; Vol. 74 (10), pp. 3049-3055.
Typ publikacji :
Journal Article
MeSH Terms :
Antifungal Agents/*therapeutic use
Hematologic Neoplasms/*drug therapy
Invasive Fungal Infections/*drug therapy
Itraconazole/*therapeutic use
Adult ; Aged ; Antibiotic Prophylaxis/methods ; Australia ; Female ; Hematopoietic Stem Cell Transplantation/methods ; Humans ; Male ; Middle Aged ; Retrospective Studies ; Stem Cell Transplantation/methods ; Young Adult
Czasopismo naukowe
Tytuł :
Anti-fungal activity of a novel triazole, PC1244, against emerging azole-resistant Aspergillus fumigatus and other species of Aspergillus.
Autorzy :
Colley T; Pulmocide Ltd, London, UK.
Sharma C; Department of Medical Mycology, Vallabhbhai Patel Chest Institute, University of Delhi, Delhi, India.
Alanio A; Institut Pasteur, CNRS, Molecular Mycology Unit, French National Reference Center for Invasive Mycoses & Antifungals, URA3012, Paris, France.; Paris Diderot, Sorbonne Paris Cité University, Paris, France.; Parasitology-Mycology Laboratory, Saint Louis Hospital, Assistance Publique-Hôpitaux de Paris (APHP), Paris, France.
Kimura G; Laboratory of Physiology and Anatomy, School of Pharmacy, Nihon University, Funabashi, Japan.
Daly L; Pulmocide Ltd, London, UK.
Nakaoki T; Laboratory of Physiology and Anatomy, School of Pharmacy, Nihon University, Funabashi, Japan.
Nishimoto Y; Laboratory of Physiology and Anatomy, School of Pharmacy, Nihon University, Funabashi, Japan.
Bretagne S; Institut Pasteur, CNRS, Molecular Mycology Unit, French National Reference Center for Invasive Mycoses & Antifungals, URA3012, Paris, France.; Paris Diderot, Sorbonne Paris Cité University, Paris, France.; Parasitology-Mycology Laboratory, Saint Louis Hospital, Assistance Publique-Hôpitaux de Paris (APHP), Paris, France.
Kizawa Y; Laboratory of Physiology and Anatomy, School of Pharmacy, Nihon University, Funabashi, Japan.
Strong P; Pulmocide Ltd, London, UK.
Rapeport G; Pulmocide Ltd, London, UK.
Ito K; Pulmocide Ltd, London, UK.
Meis JF; Department of Medical Microbiology and Infectious Diseases, Canisius Wilhelmina Hospital, Nijmegen, The Netherlands.; Center of Expertise in Mycology Radboudumc/Canisius Wilhelmina Hospital, Nijmegen, The Netherlands.
Chowdhary A; Department of Medical Mycology, Vallabhbhai Patel Chest Institute, University of Delhi, Delhi, India.
Pokaż więcej
Źródło :
The Journal of antimicrobial chemotherapy [J Antimicrob Chemother] 2019 Oct 01; Vol. 74 (10), pp. 2950-2958.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Antifungal Agents/*pharmacology
Aspergillus/*drug effects
Triazoles/*pharmacology
Animals ; Aspergillus/classification ; Aspergillus/isolation & purification ; Colony Count, Microbial ; Disease Models, Animal ; France ; Humans ; India ; Lung/microbiology ; Mannans/blood ; Mice ; Microbial Sensitivity Tests ; Netherlands ; Pulmonary Aspergillosis/microbiology ; Treatment Outcome ; Triazoles/administration & dosage
Czasopismo naukowe
Tytuł :
Antifungal susceptibility profiles of rare ascomycetous yeasts.
Autorzy :
Pérez-Hansen A; Division of Hygiene and Medical Microbiology, Medical University of Innsbruck, Schöpfstraße 41, Innsbruck, Austria.
Lass-Flörl C; Division of Hygiene and Medical Microbiology, Medical University of Innsbruck, Schöpfstraße 41, Innsbruck, Austria.
Lackner M; Division of Hygiene and Medical Microbiology, Medical University of Innsbruck, Schöpfstraße 41, Innsbruck, Austria.
Pokaż więcej
Corporate Authors :
Rare Yeast Study Group
Źródło :
The Journal of antimicrobial chemotherapy [J Antimicrob Chemother] 2019 Sep 01; Vol. 74 (9), pp. 2649-2656.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Microbial Sensitivity Tests*/methods
Microbial Sensitivity Tests*/standards
Antifungal Agents/*pharmacology
Ascomycota/*drug effects
Ascomycota/classification ; Ascomycota/isolation & purification ; Humans ; Mycoses/drug therapy ; Mycoses/microbiology ; Sensitivity and Specificity
Czasopismo naukowe
Tytuł :
Prevalence of voriconazole-resistant invasive aspergillosis and its impact on mortality in haematology patients.
Autorzy :
Resendiz-Sharpe A; Laboratory of Clinical Bacteriology and Mycology, Department of Microbiology, Immunology and Transplantation, KU Leuven, Leuven, Belgium.
Mercier T; Laboratory of Clinical Bacteriology and Mycology, Department of Microbiology, Immunology and Transplantation, KU Leuven, Leuven, Belgium.; Department of Haematology, University Hospitals Leuven, Leuven, Belgium.
Lestrade PPA; Department of Medical Microbiology, Viecuri Medical Centre, Venlo, The Netherlands.
van der Beek MT; Department of Medical Microbiology, Leiden University Medical Centre, Leiden, The Netherlands.
von dem Borne PA; Department of Haematology, Leiden University Medical Centre, Leiden, The Netherlands.
Cornelissen JJ; Department of Haematology, Erasmus Medical Centre Cancer Institute, Rotterdam, The Netherlands.
De Kort E; Department of Haematology, Radboud University Medical Centre, Nijmegen, The Netherlands.
Rijnders BJA; Department of Internal Medicine, Section of Infectious Diseases, Erasmus University Medical Centre, Rotterdam, The Netherlands.
Schauwvlieghe AFAD; Department of Internal Medicine, Section of Infectious Diseases, Erasmus University Medical Centre, Rotterdam, The Netherlands.
Verweij PE; Department of Medical Microbiology, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands; Centre of Expertise in Mycology, Radboud UMC/CWZ, Nijmegen, The Netherlands.
Maertens J; Laboratory of Clinical Bacteriology and Mycology, Department of Microbiology, Immunology and Transplantation, KU Leuven, Leuven, Belgium.; Department of Haematology, University Hospitals Leuven, Leuven, Belgium.
Lagrou K; Laboratory of Clinical Bacteriology and Mycology, Department of Microbiology, Immunology and Transplantation, KU Leuven, Leuven, Belgium.; Department of Laboratory Medicine and National Reference Center for Mycosis, Excellence Centre for Medical Mycology (ECMM), University Hospitals Leuven, Leuven, Belgium.
Pokaż więcej
Źródło :
The Journal of antimicrobial chemotherapy [J Antimicrob Chemother] 2019 Sep 01; Vol. 74 (9), pp. 2759-2766.
Typ publikacji :
Journal Article; Multicenter Study
MeSH Terms :
Drug Resistance, Fungal*
Antifungal Agents/*pharmacology
Aspergillosis/*epidemiology
Aspergillosis/*etiology
Hematologic Neoplasms/*complications
Voriconazole/*pharmacology
Aged ; Antifungal Agents/therapeutic use ; Aspergillosis/drug therapy ; Aspergillosis/mortality ; Aspergillus fumigatus/drug effects ; Aspergillus fumigatus/genetics ; Cytochrome P-450 Enzyme System/genetics ; Drug Therapy, Combination ; Female ; Fungal Proteins/genetics ; Hematologic Neoplasms/epidemiology ; Humans ; Invasive Fungal Infections/drug therapy ; Invasive Fungal Infections/epidemiology ; Invasive Fungal Infections/etiology ; Invasive Fungal Infections/mortality ; Male ; Microbial Sensitivity Tests ; Middle Aged ; Mortality ; Mutation ; Prevalence ; Prognosis ; Retrospective Studies ; Survival Analysis ; Voriconazole/therapeutic use
Czasopismo naukowe
Tytuł :
Development and multicentre validation of an agar-based screening method for echinocandin susceptibility testing of Aspergillus species.
Autorzy :
Meletiadis J; Clinical Microbiology Laboratory, Attikon University General Hospital, Medical School, National and Kapodistrian University of Athens, Athens, Greece.; Department of Medical Microbiology and Infectious Diseases, Erasmus University Medical Center, Rotterdam, The Netherlands.
Siopi M; Clinical Microbiology Laboratory, Attikon University General Hospital, Medical School, National and Kapodistrian University of Athens, Athens, Greece.
Kanioura L; Department of Medical Microbiology and Infectious Diseases, Erasmus University Medical Center, Rotterdam, The Netherlands.
Jørgensen KM; Unit of Mycology, Statens Serum Institut, Copenhagen, Denmark.
Perlin DS; Public Health Research Institute, New Jersey Medical School, Rutgers Biomedical and Health Sciences, Newark, NJ, USA.
Mouton JW; Department of Medical Microbiology and Infectious Diseases, Erasmus University Medical Center, Rotterdam, The Netherlands.
Arendrup MC; Unit of Mycology, Statens Serum Institut, Copenhagen, Denmark.; Department of Clinical Microbiology, Rigshospitalet, Copenhagen, Denmark.; Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark.
Pokaż więcej
Źródło :
The Journal of antimicrobial chemotherapy [J Antimicrob Chemother] 2019 Aug 01; Vol. 74 (8), pp. 2247-2254.
Typ publikacji :
Journal Article; Multicenter Study; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Validation Study
MeSH Terms :
Antifungal Agents/*pharmacology
Aspergillus/*drug effects
Echinocandins/*pharmacology
Microbial Sensitivity Tests/*methods
Agar ; Aspergillus/growth & development ; Culture Media ; Mass Screening/methods ; Temperature
Czasopismo naukowe
Tytuł :
Antifungal activity and killing kinetics of anidulafungin, caspofungin and amphotericin B against Candida auris.
Autorzy :
Dudiuk C; Laboratorio de Micología y Diagnóstico Molecular, Cátedra de Parasitología y Micología, Facultad de Bioquímica y Ciencias Biológicas, Universidad Nacional del Litoral, Santa Fe, Argentina.; Consejo Nacional de Investigaciones Científicas y Tecnológicas (CONICET), CCT, Santa Fe, Argentina.
Berrio I; Medical and Experimental Mycology Group, Corporación para Investigaciones Biológicas (CIB), Medellín, Colombia.; Hospital general de Medellin 'Luz Castro de Gutiérrez' ESE, Medellín, Colombia.
Leonardelli F; Laboratorio de Micología y Diagnóstico Molecular, Cátedra de Parasitología y Micología, Facultad de Bioquímica y Ciencias Biológicas, Universidad Nacional del Litoral, Santa Fe, Argentina.; Consejo Nacional de Investigaciones Científicas y Tecnológicas (CONICET), CCT, Santa Fe, Argentina.
Morales-Lopez S; Universidad de Santander, Facultad de Ciencias de la Salud, Grupo de Investigación CIENCIA UDES, Valledupar, Colombia.; Laboratorios Nancy Flórez García S.A.S., Valledupar, Colombia.
Theill L; Laboratorio de Micología y Diagnóstico Molecular, Cátedra de Parasitología y Micología, Facultad de Bioquímica y Ciencias Biológicas, Universidad Nacional del Litoral, Santa Fe, Argentina.
Macedo D; Laboratorio de Micología y Diagnóstico Molecular, Cátedra de Parasitología y Micología, Facultad de Bioquímica y Ciencias Biológicas, Universidad Nacional del Litoral, Santa Fe, Argentina.; Consejo Nacional de Investigaciones Científicas y Tecnológicas (CONICET), CCT, Santa Fe, Argentina.
Yesid-Rodriguez J; Centro de Investigaciones Microbiológicas del Cesar, CIMCE, Valledupar, Colombia.
Salcedo S; Clínica General del Norte, Barranquilla, Colombia.
Marin A; Clínica General del Norte, Barranquilla, Colombia.
Gamarra S; Laboratorio de Micología y Diagnóstico Molecular, Cátedra de Parasitología y Micología, Facultad de Bioquímica y Ciencias Biológicas, Universidad Nacional del Litoral, Santa Fe, Argentina.
Garcia-Effron G; Laboratorio de Micología y Diagnóstico Molecular, Cátedra de Parasitología y Micología, Facultad de Bioquímica y Ciencias Biológicas, Universidad Nacional del Litoral, Santa Fe, Argentina.; Consejo Nacional de Investigaciones Científicas y Tecnológicas (CONICET), CCT, Santa Fe, Argentina.
Pokaż więcej
Źródło :
The Journal of antimicrobial chemotherapy [J Antimicrob Chemother] 2019 Aug 01; Vol. 74 (8), pp. 2295-2302.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Amphotericin B/*pharmacology
Anidulafungin/*pharmacology
Antifungal Agents/*pharmacology
Candida/*drug effects
Caspofungin/*pharmacology
Microbial Viability/*drug effects
Microbial Sensitivity Tests ; Time Factors
Czasopismo naukowe
Tytuł :
Antibiotic susceptibility trend before and after long-term use of selective digestive decontamination: a 16 year ecological study.
Autorzy :
Lloréns-Villar Y; Servicio de Farmacia Hospitalaria, Hospital Universitario de Álava, Vitoria-Gasteiz, Spain.
Tusell F; Departamento de Economía Aplicada III, Facultad de Ciencias Económicas y Empresariales, Universidad del País Vasco UPV/EHU, Bilbao, Spain.
Canut A; Servicio de Microbiología, Hospital Universitario de Álava, Vitoria-Gasteiz, Spain.
Barrasa H; Servicio de Medicina Intensiva, Hospital Universitario de Álava, Vitoria-Gasteiz, Spain.
Corral E; Servicio de Medicina Intensiva, Hospital Universitario de Álava, Vitoria-Gasteiz, Spain.
Martín A; Servicio de Medicina Intensiva, Hospital Universitario de Álava, Vitoria-Gasteiz, Spain.
Rodríguez-Gascón A; Farmacia y Tecnología Farmacéutica, Facultad de Farmacia, Centro de investigación Lascaray ikergunea, Universidad del País Vasco UPV/EHU, Vitoria, Spain.
Pokaż więcej
Źródło :
The Journal of antimicrobial chemotherapy [J Antimicrob Chemother] 2019 Aug 01; Vol. 74 (8), pp. 2289-2294.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Drug Resistance, Bacterial*
Anti-Bacterial Agents/*administration & dosage
Antifungal Agents/*administration & dosage
Decontamination/*methods
Enterobacteriaceae/*drug effects
Enterococcus/*drug effects
Enterobacteriaceae/isolation & purification ; Enterococcus/isolation & purification ; Hospitals, University ; Humans ; Intensive Care Units ; Interrupted Time Series Analysis ; Microbial Sensitivity Tests ; Retrospective Studies ; Spain
Czasopismo naukowe
Tytuł :
Serial monitoring of isavuconazole blood levels during prolonged antifungal therapy.
Autorzy :
Furfaro E; Division of Infectious Diseases, Department of Health Science DISSAL, University of Genoa, Genoa, Italy.
Signori A; Section of Biostatistics, Department of Health Science DISSAL, University of Genoa, Genoa, Italy.
Di Grazia C; Division of Hematology and Bone Marrow Transplantation, IRCCS Ospedale Policlinico San Martino, Genoa, Italy.
Dominietto A; Division of Hematology and Bone Marrow Transplantation, IRCCS Ospedale Policlinico San Martino, Genoa, Italy.
Raiola AM; Division of Hematology and Bone Marrow Transplantation, IRCCS Ospedale Policlinico San Martino, Genoa, Italy.
Aquino S; Division of Hematology and Bone Marrow Transplantation, IRCCS Ospedale Policlinico San Martino, Genoa, Italy.
Ghiggi C; Division of Hematology, IRCCS Ospedale Policlinico San Martino, Genoa, Italy.
Ghiso A; Division of Hematology, IRCCS Ospedale Policlinico San Martino, Genoa, Italy.
Ungaro R; Division of Infectious Diseases, Department of Health Science DISSAL, University of Genoa, Genoa, Italy.; Division of Infectious Diseases, IRCCS Ospedale Policlinico San Martino, Genoa, Italy.
Angelucci E; Division of Hematology and Bone Marrow Transplantation, IRCCS Ospedale Policlinico San Martino, Genoa, Italy.
Viscoli C; Division of Infectious Diseases, Department of Health Science DISSAL, University of Genoa, Genoa, Italy.; Division of Infectious Diseases, IRCCS Ospedale Policlinico San Martino, Genoa, Italy.
Mikulska M; Division of Infectious Diseases, Department of Health Science DISSAL, University of Genoa, Genoa, Italy.; Division of Infectious Diseases, IRCCS Ospedale Policlinico San Martino, Genoa, Italy.
Pokaż więcej
Źródło :
The Journal of antimicrobial chemotherapy [J Antimicrob Chemother] 2019 Aug 01; Vol. 74 (8), pp. 2341-2346.
Typ publikacji :
Journal Article
MeSH Terms :
Antifungal Agents/*administration & dosage
Antifungal Agents/*pharmacokinetics
Nitriles/*administration & dosage
Nitriles/*pharmacokinetics
Pyridines/*administration & dosage
Pyridines/*pharmacokinetics
Serum/*chemistry
Triazoles/*administration & dosage
Triazoles/*pharmacokinetics
Adult ; Aged ; Aged, 80 and over ; Antifungal Agents/adverse effects ; Drug Monitoring ; Drug-Related Side Effects and Adverse Reactions/epidemiology ; Female ; Humans ; Invasive Fungal Infections/drug therapy ; Male ; Middle Aged ; Nitriles/adverse effects ; Pyridines/adverse effects ; ROC Curve ; Retrospective Studies ; Triazoles/adverse effects
Czasopismo naukowe
Tytuł :
Species distribution and antifungal susceptibility of invasive Candida isolates from Canadian hospitals: results of the CANWARD 2011-16 study.
Autorzy :
Fuller J; Department of Pathology and Laboratory Medicine, Schulich School of Medicine and Dentistry, Western University, London, Ontario, Canada.; Division of Microbiology, London Health Sciences Centre, 800 Commissioners Road E, London, Ontario, Canada.
Dingle TC; Provincial Laboratory, Alberta Health Services, 8440-112 Street, Edmonton, Alberta, Canada.; Department of Laboratory Medicine and Pathology, University of Alberta, Edmonton, Alberta, Canada.
Bull A; Provincial Laboratory, Alberta Health Services, 8440-112 Street, Edmonton, Alberta, Canada.
Shokoples S; Provincial Laboratory, Alberta Health Services, 8440-112 Street, Edmonton, Alberta, Canada.
Laverdière M; Department of Medicine, Microbiology and Infectious Diseases, Hôpital Maisonneuve-Rosemont, Montreal, Quebec, Canada.
Baxter MR; Department of Medical Microbiology/Infectious Diseases, Max Rady College of Medicine, University of Manitoba, Room 543-745 Bannatyne Avenue, Winnipeg, Manitoba, Canada.
Adam HJ; Department of Medical Microbiology/Infectious Diseases, Max Rady College of Medicine, University of Manitoba, Room 543-745 Bannatyne Avenue, Winnipeg, Manitoba, Canada.; Clinical Microbiology, Diagnostic Services Manitoba, MS673-820 Sherbrook Street, Winnipeg, Manitoba, Canada.
Karlowsky JA; Department of Medical Microbiology/Infectious Diseases, Max Rady College of Medicine, University of Manitoba, Room 543-745 Bannatyne Avenue, Winnipeg, Manitoba, Canada.; Clinical Microbiology, Diagnostic Services Manitoba, MS673-820 Sherbrook Street, Winnipeg, Manitoba, Canada.
Zhanel GG; Department of Medical Microbiology/Infectious Diseases, Max Rady College of Medicine, University of Manitoba, Room 543-745 Bannatyne Avenue, Winnipeg, Manitoba, Canada.
Pokaż więcej
Corporate Authors :
Canadian Antimicrobial Resistance Alliance (CARA) and CANWARD
Źródło :
The Journal of antimicrobial chemotherapy [J Antimicrob Chemother] 2019 Aug 01; Vol. 74 (Suppl 4), pp. iv48-iv54.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Drug Resistance, Fungal*
Antifungal Agents/*pharmacology
Candida/*drug effects
Candidiasis, Invasive/*microbiology
Adolescent ; Adult ; Aged ; Canada/epidemiology ; Candida/isolation & purification ; Candidiasis, Invasive/epidemiology ; Child ; Child, Preschool ; Epidemiological Monitoring ; Female ; Hospitals ; Humans ; Infant ; Infant, Newborn ; Male ; Middle Aged ; Prospective Studies ; Young Adult
Czasopismo naukowe
Tytuł :
Precise genome editing using a CRISPR-Cas9 method highlights the role of CoERG11 amino acid substitutions in azole resistance in Candida orthopsilosis.
Autorzy :
Morio F; Laboratoire de Parasitologie-Mycologie, CHU de Nantes, Nantes, France.; Département de Parasitologie et Mycologie Médicale, Université de Nantes, Nantes Atlantique Universités, EA1155 - IICiMed, Faculté de Pharmacie, Nantes, France.; School of Biomolecular and Biomedical Science, Conway Institute, University College Dublin, Belfield, Dublin, Ireland.
Lombardi L; School of Biomolecular and Biomedical Science, Conway Institute, University College Dublin, Belfield, Dublin, Ireland.
Binder U; Department of Hygiene, Microbiology and Public Health, Division of Hygiene and Medical Microbiology, Medical University Innsbruck, Tirol, Austria.
Loge C; Département de Chimie Thérapeutique, Université de Nantes, Nantes Atlantique Universités, EA1155 - IICiMed, Faculté de Pharmacie, Nantes, France.
Robert E; Département de Parasitologie et Mycologie Médicale, Université de Nantes, Nantes Atlantique Universités, EA1155 - IICiMed, Faculté de Pharmacie, Nantes, France.
Graessle D; Department of Hygiene, Microbiology and Public Health, Division of Hygiene and Medical Microbiology, Medical University Innsbruck, Tirol, Austria.
Bodin M; Département de Parasitologie et Mycologie Médicale, Université de Nantes, Nantes Atlantique Universités, EA1155 - IICiMed, Faculté de Pharmacie, Nantes, France.
Lass-Flörl C; Department of Hygiene, Microbiology and Public Health, Division of Hygiene and Medical Microbiology, Medical University Innsbruck, Tirol, Austria.
Butler G; School of Biomolecular and Biomedical Science, Conway Institute, University College Dublin, Belfield, Dublin, Ireland.
Le Pape P; Laboratoire de Parasitologie-Mycologie, CHU de Nantes, Nantes, France.; Département de Parasitologie et Mycologie Médicale, Université de Nantes, Nantes Atlantique Universités, EA1155 - IICiMed, Faculté de Pharmacie, Nantes, France.
Pokaż więcej
Źródło :
The Journal of antimicrobial chemotherapy [J Antimicrob Chemother] 2019 Aug 01; Vol. 74 (8), pp. 2230-2238.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Antifungal Agents/*pharmacology
Azoles/*pharmacology
Candida parapsilosis/*drug effects
Candida parapsilosis/*genetics
Cytochrome P-450 Enzyme System/*genetics
Gene Editing/*methods
Amino Acid Substitution ; CRISPR-Cas Systems ; Candidiasis/microbiology ; Drug Resistance, Fungal/genetics ; Humans ; Microbial Sensitivity Tests
Czasopismo naukowe
Tytuł :
One year prospective survey of azole resistance in Aspergillus fumigatus at a French cystic fibrosis reference centre: prevalence and mechanisms of resistance.
Autorzy :
Lavergne RA; Parasitology and Medical Mycology Laboratory, Nantes University Hospital, Nantes, France.; Parasitology and Medical Mycology Department, Nantes University, Nantes Atlantique Universities, EA1155-IICiMed, Institut de Recherche en Santé 2, Nantes, France.
Morio F; Parasitology and Medical Mycology Laboratory, Nantes University Hospital, Nantes, France.; Parasitology and Medical Mycology Department, Nantes University, Nantes Atlantique Universities, EA1155-IICiMed, Institut de Recherche en Santé 2, Nantes, France.
Danner-Boucher I; Department of Pulmonology, Cystic Fibrosis Reference Centre, Nantes University Hospital, Nantes, France.
Horeau-Langlard D; Department of Pulmonology, Cystic Fibrosis Reference Centre, Nantes University Hospital, Nantes, France.
David V; Department of Paediatrics, Nantes University Hospital, Nantes, France.
Hagen F; Department of Medical Microbiology and Infectious Diseases, Canisius-Wilhelmina Hospital, Nijmegen, The Netherlands.; Department of Medical Mycology, Westerdijk Fungal Biodiversity Institute, Utrecht, The Netherlands.
Meis JF; Department of Medical Microbiology and Infectious Diseases, Canisius-Wilhelmina Hospital, Nijmegen, The Netherlands.; Centre of Expertise in Mycology Radboudumc/CWZ, Nijmegen, The Netherlands.
Le Pape P; Parasitology and Medical Mycology Laboratory, Nantes University Hospital, Nantes, France.; Parasitology and Medical Mycology Department, Nantes University, Nantes Atlantique Universities, EA1155-IICiMed, Institut de Recherche en Santé 2, Nantes, France.
Pokaż więcej
Źródło :
The Journal of antimicrobial chemotherapy [J Antimicrob Chemother] 2019 Jul 01; Vol. 74 (7), pp. 1884-1889.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Drug Resistance, Fungal*
Antifungal Agents/*pharmacology
Aspergillosis/*epidemiology
Aspergillus fumigatus/*drug effects
Azoles/*pharmacology
Cystic Fibrosis/*complications
Adolescent ; Adult ; Aged ; Aspergillosis/microbiology ; Aspergillus fumigatus/classification ; Aspergillus fumigatus/genetics ; Aspergillus fumigatus/isolation & purification ; Child ; Child, Preschool ; Female ; France/epidemiology ; Genetic Variation ; Genotype ; Humans ; Infant ; Male ; Middle Aged ; Molecular Epidemiology ; Molecular Typing ; Mycological Typing Techniques ; Prevalence ; Prospective Studies ; Young Adult
Czasopismo naukowe
Tytuł :
Drosophila melanogaster as a model to study virulence and azole treatment of the emerging pathogen Candida auris.
Autorzy :
Wurster S; Department of Infectious Diseases, Infection Control and Employee Health, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Bandi A; Department of Infectious Diseases, Infection Control and Employee Health, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Beyda ND; Department of Pharmacy Practice and Translational Research, University of Houston College of Pharmacy, Houston, TX, USA.
Albert ND; Department of Infectious Diseases, Infection Control and Employee Health, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Raman NM; Department of Infectious Diseases, Infection Control and Employee Health, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Raad II; Department of Infectious Diseases, Infection Control and Employee Health, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Kontoyiannis DP; Department of Infectious Diseases, Infection Control and Employee Health, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Pokaż więcej
Źródło :
The Journal of antimicrobial chemotherapy [J Antimicrob Chemother] 2019 Jul 01; Vol. 74 (7), pp. 1904-1910.
Typ publikacji :
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms :
Antifungal Agents/*pharmacology
Azoles/*pharmacology
Candida/*drug effects
Candida/*pathogenicity
Candidiasis/*drug therapy
Candidiasis/*microbiology
Animals ; Animals, Genetically Modified ; Biopsy ; Candida albicans/drug effects ; Candida albicans/pathogenicity ; Candidiasis/pathology ; Disease Models, Animal ; Drosophila melanogaster ; Microbial Sensitivity Tests ; Virulence
Czasopismo naukowe
Tytuł :
In vitro interactions between isavuconazole and tacrolimus, cyclosporin A or sirolimus against Mucorales.
Autorzy :
Schwarz P; Department of Internal Medicine, Respiratory and Critical Care Medicine, University Hospital Marburg, Marburg, Germany.; Center for Invasive Mycoses and Antifungals, Philipps University Marburg, Marburg, Germany.
Schwarz PV; Center for Invasive Mycoses and Antifungals, Philipps University Marburg, Marburg, Germany.
Felske-Zech H; Department of Legal Medicine, University Hospital Gießen, Gießen, Germany.
Dannaoui E; Université Paris Descartes, Faculté de Médecine, AP-HP, Hôpital Européen Georges Pompidou, Unité de Parasitologie-Mycologie, Paris, France.; Dynamyc Research Group (EA 7380), Paris Est Créteil University, Créteil, France.
Pokaż więcej
Źródło :
The Journal of antimicrobial chemotherapy [J Antimicrob Chemother] 2019 Jul 01; Vol. 74 (7), pp. 1921-1927.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Antifungal Agents/*pharmacology
Cyclosporine/*pharmacology
Mucorales/*drug effects
Nitriles/*pharmacology
Pyridines/*pharmacology
Sirolimus/*pharmacology
Tacrolimus/*pharmacology
Triazoles/*pharmacology
Immunosuppressive Agents/pharmacology ; Microbial Sensitivity Tests ; Mucormycosis/drug therapy ; Mucormycosis/microbiology
Czasopismo naukowe
Tytuł :
Azole resistance and cyp51A mutation screening in Aspergillus fumigatus in Mexico.
Autorzy :
Gonzalez-Lara MF; Clinical Microbiology Laboratory, Instituto Nacional de Ciencias Médicasy Nutrición Salvador Zubirán, 15 Vasco de Quiroga Ave, Belisario Domínguez Sección XVI, Tlalpan, México City, México.
Roman-Montes CM; Clinical Microbiology Laboratory, Instituto Nacional de Ciencias Médicasy Nutrición Salvador Zubirán, 15 Vasco de Quiroga Ave, Belisario Domínguez Sección XVI, Tlalpan, México City, México.
Diaz-Lomeli P; Clinical Microbiology Laboratory, Instituto Nacional de Ciencias Médicasy Nutrición Salvador Zubirán, 15 Vasco de Quiroga Ave, Belisario Domínguez Sección XVI, Tlalpan, México City, México.
Rangel-Cordero A; Clinical Microbiology Laboratory, Instituto Nacional de Ciencias Médicasy Nutrición Salvador Zubirán, 15 Vasco de Quiroga Ave, Belisario Domínguez Sección XVI, Tlalpan, México City, México.
Valenzuela MO; Clinical Microbiology Laboratory, Instituto Nacional de Ciencias Médicasy Nutrición Salvador Zubirán, 15 Vasco de Quiroga Ave, Belisario Domínguez Sección XVI, Tlalpan, México City, México.
Ponce-de-Leon A; Clinical Microbiology Laboratory, Instituto Nacional de Ciencias Médicasy Nutrición Salvador Zubirán, 15 Vasco de Quiroga Ave, Belisario Domínguez Sección XVI, Tlalpan, México City, México.
Sifuentes-Osornio J; Department of Medicine, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, 15 Vasco de Quiroga Ave, Belisario Domínguez Sección XVI, Tlalpan, México City, México.
Ostrosky-Zeichner L; Department of Medicine, University of Texas Health Medical School, Houston, TX, USA.; Department of Epidemiology, Memorial Hermann Texas Medical Center, Houston, TX, USA.
Martinez-Gamboa A; Clinical Microbiology Laboratory, Instituto Nacional de Ciencias Médicasy Nutrición Salvador Zubirán, 15 Vasco de Quiroga Ave, Belisario Domínguez Sección XVI, Tlalpan, México City, México.
Pokaż więcej
Źródło :
The Journal of antimicrobial chemotherapy [J Antimicrob Chemother] 2019 Jul 01; Vol. 74 (7), pp. 2047-2050.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Drug Resistance, Fungal*
Antifungal Agents/*pharmacology
Aspergillosis/*epidemiology
Aspergillosis/*virology
Aspergillus fumigatus/*drug effects
Aspergillus fumigatus/*genetics
Azoles/*pharmacology
Cytochrome P-450 Enzyme System/*genetics
Fungal Proteins/*genetics
Antifungal Agents/therapeutic use ; Aspergillosis/drug therapy ; Azoles/therapeutic use ; Humans ; Mexico/epidemiology ; Mutation ; Public Health Surveillance
Czasopismo naukowe
Tytuł :
Posaconazole for the treatment of allergic bronchopulmonary aspergillosis in patients with cystic fibrosis.
Autorzy :
Periselneris J; Department of Respiratory Medicine, Royal Brompton & Harefield NHS Foundation Trust, London, UK.
Nwankwo L; Department of Pharmacy, Royal Brompton & Harefield NHS Foundation Trust, London, UK.
Schelenz S; Department of Microbiology, Royal Brompton & Harefield NHS Foundation Trust, London, UK.
Shah A; Department of Respiratory Medicine, Royal Brompton & Harefield NHS Foundation Trust, London, UK.
Armstrong-James D; National Heart & Lung Institute, Imperial College London, London, UK.
Pokaż więcej
Źródło :
The Journal of antimicrobial chemotherapy [J Antimicrob Chemother] 2019 Jun 01; Vol. 74 (6), pp. 1701-1703.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Antifungal Agents/*therapeutic use
Aspergillosis, Allergic Bronchopulmonary/*drug therapy
Aspergillosis, Allergic Bronchopulmonary/*etiology
Cystic Fibrosis/*complications
Triazoles/*therapeutic use
Adult ; Aspergillosis, Allergic Bronchopulmonary/diagnosis ; Disease Management ; Humans ; Immunoglobulin E/blood ; Immunoglobulin E/immunology ; Retrospective Studies ; Time Factors ; Treatment Outcome ; Young Adult
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies